Large-scale testing (Phase 3)Study completedNCT02435992What this trial is testingSafety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Celgene 1,012
Testing effectiveness (Phase 2)Study completedNCT00676832What this trial is testingStudy of COLAL-PRED to Treat Moderate to Severe Ulcerative ColitisWho this might be right forColitis, Ulcerative Prometheus Laboratories 190
Large-scale testing (Phase 3)Study completedNCT03996369What this trial is testingEtrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Arena Pharmaceuticals 354
Large-scale testing (Phase 3)Study completedNCT02499783What this trial is testingStudy to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease AbbVie 205
Not applicableNo Longer AvailableNCT03362736What this trial is testingAn Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT02877134What this trial is testingSafety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC 388
Testing effectiveness (Phase 2)Looking for participantsNCT07415044What this trial is testingLY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe Eli Lilly and Company 1,431
Testing effectiveness (Phase 2)Looking for participantsNCT07083193What this trial is testingAC-101 Tablets in Participants With Moderate to Severe Active Ulcerative ColitisWho this might be right forUlcerative Colitis Accro Bioscience (Suzhou) Limited 24
Large-scale testing (Phase 3)Study completedNCT01369342What this trial is testingEvaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)Who this might be right forCrohn's DiseaseInflammatory Bowel DiseaseIBD+1 more Janssen Research & Development, LLC 640
Testing effectiveness (Phase 2)Ended earlyNCT03341962What this trial is testingPhase 2 Dose-finding IMU-838 for Ulcerative ColitisWho this might be right forUlcerative Colitis Immunic AG 263
Testing effectiveness (Phase 2)Study completedNCT02378688What this trial is testingSafety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's DiseaseWho this might be right forCrohn's Disease Tanabe Pharma Corporation 78
Large-scale testing (Phase 3)Study completedNCT03464136What this trial is testingSafety and Efficacy of Adalimumab Versus Ustekinumab for One YearWho this might be right forCrohn Disease Janssen Scientific Affairs, LLC 386
Post-approval studies (Phase 4)Looking for participantsNCT05928039What this trial is testingPATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's DiseaseWho this might be right forCrohn Disease University of Calgary 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242471What this trial is testingCombination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Janssen Research & Development, LLC 703
Large-scale testing (Phase 3)Looking for participantsNCT07577856What this trial is testingJNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forColitis, Ulcerative Janssen Research & Development, LLC 644
Testing effectiveness (Phase 2)Ended earlyNCT03201445What this trial is testingStudy to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel DiseaseWho this might be right forInflammatory Bowel Disease Lakefront Biotherapeutics NV 139
Large-scale testing (Phase 3)Looking for participantsNCT05923073What this trial is testingGuselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Janssen Research & Development, LLC 120
Post-approval studies (Phase 4)Looking for participantsNCT06045754What this trial is testingVedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 50
Testing effectiveness (Phase 2)Looking for participantsNCT06636656What this trial is testingTest Whether BI 3032950 Helps People With Ulcerative ColitisWho this might be right forUlcerative Colitis Boehringer Ingelheim 80
Not applicableAvailableNCT06856135What this trial is testingExpanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USAWho this might be right forCrohn's DiseaseUlcerative Colitis Takeda